|
Diagnostics Biochem Canada Inc.（DBC）是一家自1973年成立以來一直致力于研發(fā)和銷售在診斷和公共衛(wèi)生領(lǐng)域發(fā)揮重要作用的獨(dú)特免疫檢測(cè)試劑盒。DBC公司始終以為全球用戶提供更多樣、更簡(jiǎn)單易用的診斷試劑盒為宗旨； 作為一家面向全球市場(chǎng)的高質(zhì)量免疫檢測(cè)產(chǎn)品的制造商，DBC一直在探索新的技術(shù)，用于改善疾病的診斷，并最終造福全世界人民的生活品質(zhì)。
DBC一直堅(jiān)持用高標(biāo)準(zhǔn)從事產(chǎn)品的開發(fā)和生產(chǎn)，公司通過了ISO13485：2016（MDSAP）認(rèn)證，DBC將以不斷提升客戶滿意度為目標(biāo)，持續(xù)提供更多更優(yōu)質(zhì)的產(chǎn)品。
At Diagnostics Biochem Canada Inc. (DBC), it has been our mission for over 45 years to develop and market unique immunoassay kits that make a difference in the field of diagnostics and in public health. As a manufacturer of high quality immunoassays to a global market, we are constantly looking for new technologies and applications that can lead to an improvement in the diagnosis of disease and ultimately impact the quality of life for people around the world.
DBC was founded in 1973 by a partnership of medical doctors with the initiative to research, develop and market quality radioimmunoassay kits and reagents. As technology in the field progressed the founders of DBC recognized the need to develop simple and non-isotopic kits for our customers. With a strong research initiative, DBC successfully converted from RIA to the ELISA and LIA technologies of today.
We have been exporting our products around the globe for over 40 years. As a leader in the industry, it has always been our goal to offer a wide range of test kits and continually introduce new and unique products to the market place. It is our strong commitment to research and development that has enabled us to offer our customers ongoing and unique products.
Address: 384 Neptune Crescent. London, Ontario, Canada. N6M 1A1
|
